Healthcare - Sector
MCRB is currently covered by 1 analysts with an average price target of $22. This is a potential upside of $20.67 (1554.14%) from yesterday's end of day stock price of $1.33.
Seres Therapeutics's activity chart (see below) currently has 68 price targets and 71 ratings on display. The stock rating distribution of MCRB is 100% BUY.
Analysts' price targets on this stock were met 55.6% of the time, taking 304.13 days on average.
Highest price target for MCRB is $22, Lowest price target is $22, average price target is $22.
Most recent stock forecast was given by JOHN NEWMAN from CANACCORD on 13-Mar-2026. First documented stock forecast 22-Oct-2015.
Currently out of the existing stock ratings of MCRB, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Aug-2020
$22
$20.6 (1471.43%)
$22
8 months 6 days ago
(13-Mar-2026)
1/5 (20%)
$13.37 (154.92%)
55
Buy Since 09-Jul-2021
$6
1 years 6 months 11 days ago
(08-May-2025)
1/5 (20%)
$-0.96 (-13.79%)
400
Sell Since 14-Mar-2025
1 years 8 months 5 days ago
(14-Mar-2025)
3/3 (100%)
$-1 (-3.85%)
119
Sell Since 24-Oct-2024
$140
2 years 26 days ago
(24-Oct-2024)
0/1 (0%)
$11.2 (8.70%)
Buy Since 03-Nov-2023
$4
2 years 5 months 12 days ago
(07-Jun-2024)
4/4 (100%)
$-16.6 (-80.58%)
680
What is MCRB (Seres Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on MCRB (Seres Therapeutics)?
Which analyst has the most public recommendations on MCRB (Seres Therapeutics)?
Which analyst is the currently most bullish on MCRB (Seres Therapeutics)?
Which analyst is the currently most reserved on MCRB (Seres Therapeutics)?